ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Who’s Going to ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

388 organizations and 134 speakers at the European Laboratory Research & Innovation Group (ELRIG) Drug Discovery 2026, a ~3,000-person, mostly industry meeting of European drug discovery scientists, free to attend. As of Oct 8, 2026.

Showing 1–10 of 388 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
GSK London, UK	◆Partner
gsk.com Large pharmaPartner Global biopharmaceutical company developing vaccines and specialty medicines in infectious disease, HIV, respiratory, immunology and oncology.	Booth Exhibiting at Booth CZ02 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with Nottingham Trent University Talk Wed Oct 14 11:20am–11:50am Biophysics: A Look Back at Changing Tools and Changing Questions Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:00pm–2:30pm Designing Smarter Experiments: Connecting DoE, Laboratory Automation and AI in a Translational Discovery Workflow Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 2:00pm–2:30pm Sarcoma patient derived 3D cell culture models for drug discovery and prediction of the clinical trials outcome Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 2:40pm–3:10pm Patient-Derived Intestinal Organoids: Advancing Gut Complexity for Drug Discovery and Development Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 5:30pm–6:30pm Early Career Professionals: Network Like A Boss Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on. Learning Zone with Liverpool School of Tropical Medicine Panel Thu Oct 15 9:30am–10:15am Keynote Panel - 20 Years of Discovery: Lessons from the Past, Blueprints for the Next 20 What two decades of change in drug discovery, from high-throughput screening to AI design, teach about building the next generation of medicines. Auditorium 1 with Constructive Bio, Omega Funds, OtoImmune +1 more Talk Thu Oct 15 2:30pm–3:00pm Automated Molecular Design in BRADSHAW: Application to GSK Projects Auditorium 3 AI in medicinal chemistry
University College London London, UK
ucl.ac.uk Academic & healthcare Public research university in London.	Talk Wed Oct 14 3:45pm–4:15pm Therapeutic application of “ready-made” base-edited CAR T cells in leukaemia Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm Mindful Conversations: Building Trust with Black Communities as a Foundation for Inclusive Dementia Research Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development Talk Thu Oct 15 3:00pm–3:30pm Bridging the Translation Gap: How Core Facilities Turn High‑Dimensional Cytometry Into Clinically Meaningful Outcomes Auditorium 1 From multi-omics to clinical outcomes: Insights for drug development
Pharmaron Beijing, China	◆Conference Partner
pharmaron.com CROs & CDMOsConference Partner Contract research, development and manufacturing provider covering small molecules, biologics and cell and gene therapy, with integrated discovery teams from hit to candidate.	Booth Exhibiting at Booth D12, D13 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Thu Oct 15 10:50am–10:55am Track Chair - AI in medicinal chemistry How AI and machine learning are changing drug discovery, covering compound quality, links to lab validation and newer AI tools. Auditorium 3 with IUPAC, Royal Society of Chemistry Talk Thu Oct 15 11:25am–11:55am A CNS‑Focused Approach to Selective PARP1 Drug Discovery How chemists designed a selective, brain-penetrant oral inhibitor for brain cancers, aiming to avoid the blood toxicities that limit older drugs. Exhibition Hall Theatre
The Francis Crick Institute London, UK
crick.ac.uk Academic & healthcare Biomedical research institute in London.	Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with AstraZeneca Talk Wed Oct 14 11:20am–11:50am The drugs are in the details: A microscopy-based CRISPR screen reveals unexpected vulnerabilities of a neglected parasitic disease Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application
LifeArc London, UK	◆Partner
lifearc.org Gov/NGOPartner UK medical research charity that funds and runs translational research and drug discovery to move science toward patients.	Booth Exhibiting at Booth CZ03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, Novo Nordisk, Novartis Talk Wed Oct 14 9:25am–10:10am Plenary Keynote - Where Need Meets Momentum: The Next 20 Years Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
Ignota Labs Cambridge, UK
ignotalabs.ai Biotech AI company rescuing failed or shelved drug candidates by solving safety problems and creating new chemistry and IP.	Talk Thu Oct 15 12:40pm–1:10pm Giving failed drugs a second chance with AI Auditorium 3 AI in medicinal chemistry Panel Thu Oct 15 3:30pm–4:00pm Panel session - Beyond the Pitch: Navigating the Highs and Lows of Entrepreneurship Breakthrough Zone Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Creasallis, MFX
Imperial College London London, UK
imperial.ac.uk Academic & healthcare London research university in science, engineering, medicine and business.	Talk Thu Oct 15 11:55am–12:25pm Beyond Protein Expression: Singel-Cell Spatial Protein Organization in Autoimmune Disease Auditorium 1 From multi-omics to clinical outcomes: Insights for drug development Talk Thu Oct 15 3:00pm–3:30pm Developing a Drug Pipeline for a Multi-arm Multi-stage Platform Trial in Clinical Alzheimer’s Disease Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development
IQVIA Durham, NC
iqvia.com CROs & CDMOs Clinical research and health data company whose laboratories business runs drug discovery biology, DMPK and translational assay work for clients.	Talk Wed Oct 14 12:20pm–12:50pm Optimising and Miniaturising Translational Assays to Enable AI-Driven Drug Discovery, Harnessing Modern Laboratory Automation and Design of Experiments Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with AstraZeneca, Cambridge Consultants
UK Dementia Research Institute London, UK
ukdri.ac.uk Academic & healthcare National research institute studying dementia and neurodegenerative disease through centres hosted at UK universities.	Chair Thu Oct 15 10:50am–10:55am Track Chair - Inclusive translational approaches to accelerate equitable neuroscience drug development What it takes to move neurological drugs through clinical trials, from trial design and patient grouping to diverse enrolment and regulatory expectations. Exhibition Hall Theatre with Northumbria University Talk Thu Oct 15 10:55am–11:25am From High throughput Phenotypic Drug Screening to Clinical Trials: Advancing ALS/MND Therapeutics Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development

Instantly find 20 buyers from companies at ELRIG Drug Discovery 2026

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where was ELRIG Drug Discovery 2026?

ELRIG Drug Discovery 2026 ran October 14–15, 2026, at ExCeL London in London, UK.

What conference is this?

ELRIG Drug Discovery is the European Laboratory Research & Innovation Group’s free annual meeting for drug discovery scientists, held October 14–15, 2026 at ExCeL London — its 20th edition. It brings together pharma, biotech, CRO and academic scientists with the instrument, reagent, software and service companies that supply them, across tracks on cell-based models, AI and lab-in-the-loop discovery, CRISPR, multi-omics, biophysics, imaging, radioligands and bioconjugates, microbiology, translational science, sample management and start-ups.

What is in this guide?

Every organization we can place at ELRIG Drug Discovery 2026: the 264 exhibitors from ELRIG’s exhibitor list with their stand numbers (Breakthrough Zone start-ups have a pod in the zone rather than a numbered stand), 46 sponsors with a Consultancy Café table, a commercial poster or another package but no stand, and 134 speakers from the public agenda (140 sessions, vendor slots included) rolled up to their companies and institutions — 388 organizations in one list. Speakers appear as job titles, never by name.

How are organizations typed?

By the role an organization plays in drug discovery: drug developers (large pharma and biotech), then the companies around them — CROs and CDMOs, instrument and lab automation makers, reagent, assay and model-system suppliers, software and AI companies, and consultancies and other services — and academic, healthcare, government and non-profit bodies. The topic filters come from the track a session sits in, and for exhibitors from their own profile.

How current is it?

Pulled from the event’s public agenda, speaker list, exhibitor list and sponsor list on October 8, 2026, six days before the meeting. Exhibition hours are from ELRIG’s show guide.

Browse ELRIG Drug Discovery 2026 by

Organization type

Topic

Exhibit hall

Exhibitors 264

Everyone

All organizations A–Z 388

Organizations with their own page

322 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by ELRIG. Submit a correction